NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.

Maximilian Meyer, C. Felix Mosandl, Adrian Guessoum, Oliver Herrmann, Lavinia Baltes-Flückiger, Eva-Maria Pichler +10 more

Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are biomarkers for neuroaxonal damage and astroglial injury, respectively. The present study aimed to quantify NfL and GFAP as well as investigate their association with psychiatric symptoms in a sample of recreational cannabis users. Blood samples from 331 individuals with regular recreational cannabis use were collected. Serum NfL (sNfL)…

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis

Christoph Felix Mosandl, Lavinia Baltes-Flückiger, Jens Kronschnabel, Maximilian Meyer, Adrian Guessoum, Oliver Herrmann +3 more

Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial

Lavinia Baltes-Flueckiger, Regine Steinauer, Maximilian Meyer, Marc Vogel, Marc Walter

BackgroundCannabis is the most widely used illicit substance. Various countries have legalized cannabis for recreational use. Evidence on the health effects of cannabis regulation remains unclear and is mainly based on observational studies. To date, there is no randomized controlled study evaluating the impact of cannabis regulation for recreational use compared to the illicit market on relevant health indicators…